Search

everythinglearnresearchcommunity

for

Search:↓

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

The skin communicates with the nervous system, and targeting neurohormones like melatonin and oxytocin could help treat skin issues.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

EGFR signaling is crucial for skin and hair health, and targeting it could help treat skin diseases and cancer.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Changes in certain RNA and protein levels may contribute to alopecia areata and could be treatment targets.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Alopecia areata progression is linked to stress and hormone changes, suggesting new treatment targets.

New insights into skin damage from UV exposure suggest potential treatments, including targeting specific RNAs and combining therapies for better outcomes.

Staphylococcus aureus affects immune responses and skin cells in atopic dermatitis, suggesting new treatment targets.

NLRP3 helps control inflammation and repair in wound healing, making it a potential target for treatment.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

A systems biology approach helps improve mesenchymal stromal cell therapies by mapping interactions and identifying treatment targets.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.